Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI

• Martine Aubert,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Byoung Y. Ryu,

  Affiliation Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, United States of America

  ⨯
• Lindsey Banks,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• David J. Rawlings,

  Affiliation Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, United States of America

  ⨯
• Andrew M. Scharenberg,

  Affiliation Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, United States of America

  ⨯
• Keith R. Jerome

  * E-mail: kjerome@fhcrc.org

  Affiliations Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯